226 related articles for article (PubMed ID: 12885811)
1. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.
Ilson DH; Bains M; Kelsen DP; O'Reilly E; Karpeh M; Coit D; Rusch V; Gonen M; Wilson K; Minsky BD
J Clin Oncol; 2003 Aug; 21(15):2926-32. PubMed ID: 12885811
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan, cisplatin, and radiation in esophageal cancer.
Ilson DH; Minsky B; Kelsen D
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):11-5. PubMed ID: 12109799
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
[TBL] [Abstract][Full Text] [Related]
4. Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer.
Knox JJ; Wong R; Visbal AL; Horgan AM; Guindi M; Hornby J; Xu W; Ringash J; Keshavjee S; Chen E; Haider M; Darling G
Cancer; 2010 Sep; 116(17):4023-32. PubMed ID: 20533506
[TBL] [Abstract][Full Text] [Related]
5. Irinotecan in esophageal cancer.
Ilson DH; Minsky B
Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):32-6. PubMed ID: 14569846
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer.
Ilson DH
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):22-5. PubMed ID: 15685830
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
Johnson FM; Kurie JM; Peeples BO; Lee JJ; Feng L; Pisters KM; Fossella FV; Papadimitrakopoulou VA; Blumenschein GR; Komaki R; Glisson BS
Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
Langer CJ; Somer R; Litwin S; Feigenberg S; Movsas B; Maiale C; Sherman E; Millenson M; Nicoloau N; Huang C; Treat J
J Thorac Oncol; 2007 Mar; 2(3):203-9. PubMed ID: 17410043
[TBL] [Abstract][Full Text] [Related]
10. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
11. Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
Watkins JM; Zauls AJ; Kearney PL; Shirai K; Ruppert BN; Harper JL; Sherman CA; Aguero EG; Reed CE; Sharma AK
Jpn J Clin Oncol; 2011 Mar; 41(3):334-42. PubMed ID: 21084436
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.
Ilson DH; Saltz L; Enzinger P; Huang Y; Kornblith A; Gollub M; O'Reilly E; Schwartz G; DeGroff J; Gonzalez G; Kelsen DP
J Clin Oncol; 1999 Oct; 17(10):3270-5. PubMed ID: 10506629
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
14. Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas.
Sun W; Metz JM; Gallagher M; O'Dwyer PJ; Giantonio B; Whittington R; Haller DG
Cancer Chemother Pharmacol; 2011 Mar; 67(3):621-7. PubMed ID: 20495918
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I study.
Klautke G; Fähndrich S; Semrau S; Büscher C; Virchow C; Fietkau R
Lung Cancer; 2006 Aug; 53(2):183-8. PubMed ID: 16757061
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
[TBL] [Abstract][Full Text] [Related]
17. Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial.
Michel P; Adenis A; Di Fiore F; Boucher E; Galais MP; Dahan L; Mirabel X; Hamidou H; Raoul JL; Jacob JH; Hellot MF; Prod'homme S; Paillot B
Br J Cancer; 2006 Sep; 95(6):705-9. PubMed ID: 16967056
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer.
Hihara J; Yoshida K; Hamai Y; Emi M; Yamaguchi Y; Wadasaki K
Anticancer Res; 2007; 27(4C):2597-603. PubMed ID: 17695421
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma.
Rivera F; Galán M; Tabernero J; Cervantes A; Vega-Villegas ME; Gallego J; Laquente B; Rodríguez E; Carrato A; Escudero P; Massutí B; Alonso-Orduña V; Cardenal A; Sáenz A; Giralt J; Yuste AL; Antón A; Aranda E;
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1430-6. PubMed ID: 19540072
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.
Ilson DH; Minsky BD; Ku GY; Rusch V; Rizk N; Shah M; Kelsen DP; Capanu M; Tang L; Campbell J; Bains M
Cancer; 2012 Jun; 118(11):2820-7. PubMed ID: 21990000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]